Skip to search formSkip to main contentSkip to account menu

Xen2174

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
DEVELOPMENT OF XEN2174: NON-CLINICAL STUDIES AND AN OPEN-LABEL I/IIa STUDY OF INTRATHECAL USE IN ONCOLOGY PATIENTS WITH MODERATE TO SEVERE PAIN
Review
2008
Review
2008
Future Directions for Intrathecal Pain Management: A Review and Update From the Interdisciplinary Polyanalgesic Consensus Conference 2007
Background.  Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000… 
2005
2005
Intrathecal XEN2174 produces significant anti-allodynia in morphine-tolerant rats using the CCI-model of persistent neuropathic pain
2004
2004
Anti-allodynic effects of Xen2174 in rats with neuropathy. Abstract
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)